Longevity AI

The market cap of Longevity AI is $6.0K.

The 24-hour trading volume for LONGAI is $0.32.

Longevity AI (LONGAI) can be traded on: Raydium.

Unlike general-purpose AI research assistants, Longevity AI markets itself as a decentralized, blockchain-based agent designed to autonomously navigate and synthesize preprints from bioRxiv and medRxiv. The project’s novelty lies in its tokenized approach, where users might ostensibly contribute to or benefit from AI-driven insights via $LONGAI, though no functional mechanism for this integration has been demonstrated. Most competitors in the DeSci space rely on centralized models or curated datasets, leaving open questions about whether decentralization adds meaningful value or if it’s merely a marketing gimmick to attract Longevity-focused investors.

The project implies that both longevity researchers and crypto-native investors would use $LONGAI to access AI-generated insights or participate in governance, but no clear user onboarding or product interface has been outlined. Given the project’s Solana launch and meme-coin branding, it’s likely targeting speculative traders and DeSci enthusiasts rather than professional bioinformaticians. Without a functional demo, visions of researchers submitting queries or token holders voting on research priorities remain theoretical at best.

The absence of audits raises immediate red flags about smart contract security and project transparency, especially for a token operating on a high-speed chain like Solana where rug pulls and exploits are not uncommon. Meanwhile, the paltry 4 daily transactions highlight a near-nonexistent organic user base, suggesting that any price movement would be driven by speculative interest rather than real utility. For a micro-cap asset with downtrending sentiment, the combination of illiquidity and unproven technology creates a high-risk environment where exit liquidity could vanish as quickly as it appeared.